Cell and gene therapy continues to be on the rise, but is your CDMO new to the market? In this webinar, Ajinomoto Bio-Pharma Services explores the benefits of working with a CDMO that has extensive plasmid experience and integrated project teams across the production process.
Capacity, lead-times, and consistency in yield are all challenges presented during development through commercialization of plasmids. Collaborating with your CDMO partner on a manufacturing strategy that is phase-appropriate can alleviate concerns on those challenges. This presentation will delve into the pros and cons of a full GMP plasmid production approach as compared to research grade during early stage projects. Understanding these crucial factors while selecting a partner will help ensure the quality of the critical raw materials for your product throughout its lifecycle.
Explore best practices to help avoid common pitfalls such as timelines, communication, and cost and review challenges that can arise from regulatory requirements.